Related references
Note: Only part of the references are listed.Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0, Tyr3] octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors
Tessa Brabander et al.
CLINICAL CANCER RESEARCH (2017)
Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors
K. Kamp et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET
Annarita Ianniello et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trials
Mauro Cives et al.
CURRENT OPINION IN ONCOLOGY (2016)
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
M. Falconi et al.
NEUROENDOCRINOLOGY (2016)
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
M. Pavel et al.
NEUROENDOCRINOLOGY (2016)
Ketoconazole induces apoptosis in rat cardiomyocytes through reactive oxygen species-mediated parkin overexpression
Kyung Jong Won et al.
ARCHIVES OF TOXICOLOGY (2015)
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature
M. Fraenkel et al.
ENDOCRINE-RELATED CANCER (2014)
The Soft Agar Colony Formation Assay
Stanley Borowicz et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Medical Treatment of Cushing's Disease
Richard A. Feelders et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned
James C. Yao et al.
ONCOLOGIST (2013)
Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion
S. T. Sharma et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Endoscopic bilateral adrenalectomy in patients with ectopic Cushing's syndrome
Wijnand J. Alberda et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2012)
A Case of Ectopic Adrenocorticotropic Hormone-producing Pancreatic Neuroendocrine Tumor with Multiple Liver Metastases
Tatsuya Kondo et al.
ENDOCRINE JOURNAL (2010)
Paraneoplastic syndromes secondary to neuroendocrine tumours
Gregory Kaltsas et al.
ENDOCRINE-RELATED CANCER (2010)
A Phase I Clinical Study of High Dose Ketoconazole Plus Weekly Docetaxel for Metastatic Castration Resistant Prostate Cancer
William D. Figg et al.
JOURNAL OF UROLOGY (2010)
Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
Christiaan de Bruin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Ketoconazole-induced JNK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells
Ko-Long Lin et al.
TOXICOLOGY IN VITRO (2009)
Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors
Amy Moreno et al.
ENDOCRINE-RELATED CANCER (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
The ectopic adrenocorticotropin syndrome: Clinical features, diagnosis, management, and long-term follow-up
AM Isidori et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients
J van der Hoek et al.
CLINICAL ENDOCRINOLOGY (2005)
Long-term outcome for men with androgen independent prostate cancer treated with ketoconazole and hydrocortisone
M Scholz et al.
JOURNAL OF UROLOGY (2005)
Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3] octreotate in patients with endocrine gastroenteropancreatic tumors
DJ Kwekkeboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome?
GL Uwaifo et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2003)
Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes
D Ferone et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile
C Bruns et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Ketoconazole potentiates terfenadine-induced apoptosis in human Hep G2 cells through inhibition of cytochrome p450 3A4 activity
YJ Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Ketoconazole induces G0/G1 arrest in human colorectal and hepatocellular carcinoma cell lines
RJ Chen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2000)
Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment
RT Jensen
CURRENT OPINION IN ONCOLOGY (2000)
Share Paper
